Department of Internal Medicine, University of Bonn, Sigmund-Freud-Strasse 25, Bonn D-53105, Germany.
Gut. 2010 Jun;59(6):808-16. doi: 10.1136/gut.2008.157818. Epub 2009 Dec 1.
Autoimmune hepatitis and primary sclerosing cholangitis are chronic inflammatory disorders of unknown aetiology, frequently associated with the presence of perinuclear antineutrophil cytoplasmic antibodies (p-ANCAs) directed against an unknown antigen of myeloid cells.
Here, it is reported that p-ANCAs in autoimmune liver disorders react with beta-tubulin isotype 5 (TBB-5) as autoantigen as well as with its evolutionary bacterial precursor protein FtsZ. Both proteins were confirmed as antigens of p-ANCAs in autoimmune liver disorders by demonstrating reactivity of ANCA-positive sera with recombinant TBB-5 (72-88%) and FtsZ (64-82%) on immunoblots and antigen-specific abrogation of ANCA immunofluorescence when sera had been preabsorbed with tubulin and FtsZ. Using sera from interleukin 10-deficient mice (Il10(-)/(-)), an animal model of inflammatory bowel disease, it was also demonstrated that antibodies against TBB-5 are generated in response to intestinal microorganisms. However, unlike autoimmune liver disorders, human antibodies to FtsZ in the absence of TBB-5 antibodies were also a frequent finding in non-autoimmune liver diseases (up to 95%). Reactivity to TBB-5 without the presence of FtsZ antibodies was found in very few cases (<1%) in autoimmune liver disorders.
Thus, p-ANCAs in autoimmune liver diseases are directed against human TBB-5 cross-reacting with the bacterial protein FtsZ, probably reflecting an abnormal immune response to intestinal microorganisms in susceptible, possibly genetically predisposed individuals.
自身免疫性肝炎和原发性硬化性胆管炎是病因不明的慢性炎症性疾病,常伴有核周抗中性粒细胞胞浆抗体(p-ANCAs),该抗体针对髓样细胞的未知抗原。
本研究报道,自身免疫性肝疾病中的 p-ANCAs 不仅与β-微管蛋白异构体 5(TBB-5)作为自身抗原发生反应,还与进化细菌前体蛋白 FtsZ 发生反应。通过证明 ANCA 阳性血清与重组 TBB-5(72-88%)和 FtsZ(64-82%)在免疫印迹上的反应性,以及当血清用微管蛋白和 FtsZ 预吸收时 ANCA 免疫荧光的抗原特异性阻断,证实了这两种蛋白均为自身免疫性肝疾病 p-ANCAs 的抗原。使用白细胞介素 10 缺陷小鼠(Il10(-)/(-))的血清,一种炎症性肠病的动物模型,也证明了针对 TBB-5 的抗体是针对肠道微生物产生的。然而,与自身免疫性肝疾病不同,在没有 TBB-5 抗体的情况下,人类针对 FtsZ 的抗体也是非自身免疫性肝疾病(高达 95%)的常见发现。在自身免疫性肝疾病中,很少有病例(<1%)出现仅对 TBB-5 有反应而无 FtsZ 抗体的情况。
因此,自身免疫性肝疾病中的 p-ANCAs 针对人类 TBB-5,与细菌蛋白 FtsZ 发生交叉反应,可能反映了对易感、可能存在遗传易感性个体的肠道微生物的异常免疫反应。